Safety and efficacy of CRISPR-mediated genome ablation of VEGFA as a treatment for choroidal neovascularization in nonhuman primate eyes.
Sin TN, Tng N, Dragoli J, Ramesh Kumar S, Villafuerte-Trisolini C, Chung SH, Tu L, Le SM, Shim JH, Pepple KL, Ravindran R, Khan IH, Moshiri A, Thomasy SM, Yiu G.
Sin TN, et al. Among authors: khan ih.
Mol Ther. 2024 Sep 27:S1525-0016(24)00651-8. doi: 10.1016/j.ymthe.2024.09.027. Online ahead of print.
Mol Ther. 2024.
PMID: 39342431